These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 458986)

  • 21. The immunological features of Peyronie's disease.
    Ralph DJ; Mirakian R; Pryor JP; Bottazzo GF
    J Urol; 1996 Jan; 155(1):159-62. PubMed ID: 7490821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is high levels of vitamin D a new risk factor for Peyronie's disease?
    Canat HL; Can O; Ozbir S; Cakir SS; Culha MG; Bayraktarli RY; Atalay HA
    Andrologia; 2019 Oct; 51(9):e13368. PubMed ID: 31482615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of increased transforming growth factor beta protein expression in the pathogenesis of Peyronie's disease.
    Hassoba H; El-Sakka A; Lue T
    Egypt J Immunol; 2005; 12(1):1-8. PubMed ID: 16734133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peyronie's disease is associated with Paget's disease of bone.
    Lyles KW; Gold DT; Newton RA; Parekh S; Shipp KM; Pieper CF; Krishan R; Carson CC
    J Bone Miner Res; 1997 Jun; 12(6):929-34. PubMed ID: 9169352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of Peyronie's disease with HLA B7 cross-reactive antigens. A case report of identical twins.
    Ziegelbaum M; Thomas A; Zachary AA
    Cleve Clin J Med; 1987; 54(5):427-30. PubMed ID: 3499260
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease.
    Stewart S; Malto M; Sandberg L; Colburn KK
    J Urol; 1994 Jul; 152(1):105-6. PubMed ID: 8201639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated in the aetiology of peyronie's disease.
    Chilton CP; Castle WM; Westwood CA; Pryor JP
    Br J Urol; 1982 Dec; 54(6):748-50. PubMed ID: 7150935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire.
    Hellstrom WJ; Feldman R; Rosen RC; Smith T; Kaufman G; Tursi J
    J Urol; 2013 Aug; 190(2):627-34. PubMed ID: 23376705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic findings in Peyronie's disease: a controlled study.
    Schiavino D; Sasso F; Nucera E; Alcini E; Gulino G; Milani A; Patriarca G
    Urology; 1997 Nov; 50(5):764-8. PubMed ID: 9372889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peyronie's disease: etiology, medical, and surgical therapy.
    Hellstrom WJ; Bivalacqua TJ
    J Androl; 2000; 21(3):347-54. PubMed ID: 10819440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penile prosthesis implantation in the treatment of Peyronie's disease.
    Carson CC
    Int J Impot Res; 1998 Jun; 10(2):125-8. PubMed ID: 9647951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentations of Peyronie's disease.
    Pryor JP; Ralph DJ
    Int J Impot Res; 2002 Oct; 14(5):414-7. PubMed ID: 12454695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Peyronie's disease: an update].
    Zhu XB; Jiang R
    Zhonghua Nan Ke Xue; 2013 Apr; 19(4):355-9. PubMed ID: 23678718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peyronie's disease.
    Horton CE; Sadove RC; Devine CJ
    Ann Plast Surg; 1987 Feb; 18(2):122-7. PubMed ID: 3551750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.
    El-Sakka AI; Hassoba HM; Pillarisetty RJ; Dahiya R; Lue TF
    J Urol; 1997 Oct; 158(4):1391-4. PubMed ID: 9302128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between diabetes mellitus, impotence and veno-occlusive dysfunction in Peyronie's disease patients.
    Culha M; Alici B; Acar O; Mutlu N; Gökalp A
    Urol Int; 1998; 60(2):101-4. PubMed ID: 9563148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application of traction therapy for Peyronie's disease: present and prospect].
    He ZH; Lu YP
    Zhonghua Nan Ke Xue; 2014 Jan; 20(1):78-82. PubMed ID: 24527543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical characteristics of Peyronie's patients with notching deformity.
    Cakan M; Akman T; Oktar T; Gurkan L; Celtik M; Kadioglu A
    J Sex Med; 2007 Jul; 4(4 Pt 2):1174-8. PubMed ID: 17662024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.